Yidu Tech Affiliate Wins Xi'an Jiaotong University First Affiliated Hospital Infectious Disease Big Data Platform Project Worth RMB 14.945 Million

Stock News
Sep 28

Yidu Tech (02158) announced that its affiliate Yidu Cloud (Beijing) Technology Co., Ltd. has successfully won the bid for the infectious disease intelligent early warning system, infectious disease surveillance and epidemiological investigation virtual simulation training center, and infectious disease big data platform project of the First Affiliated Hospital of Xi'an Jiaotong University School of Medicine, with a total project amount of approximately RMB 14.945 million.

Yidu Tech is a core force driving the intelligent upgrade of China's healthcare system. The group deeply empowers the entire industry chain of "medical services, pharmaceuticals, insurance, and patients" with intelligent decision-making, committed to making precision medicine accessible to everyone.

By simulating doctors' clinical decision-making logic, using real disease progression as training targets, and repeatedly validating in the real world, the group has created "AI that truly understands diseases" and provides measurable value to key links in the healthcare ecosystem: enabling doctors to have more precise and efficient decision-making tools, helping pharmaceutical companies shorten the distance from molecules to patients, allowing patients to enjoy more affordable precision diagnosis and treatment, and enabling public systems to obtain more scientific support.

Yidu Tech, with independently innovative system-level intelligence, creates a more resilient, more caring, and more inclusive and efficient healthcare future.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10